Company intelligence / Profile preview

Heyden Chemical

West Windsor, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Heyden Chemical manufactured penicillin, streptomycin, and candicidin at scale for infection treatment, including producing a thermostable penicillin during WWII and expanding output to support military needs. The company was later acquired by American Cyanamid in 1953.

Therapeutic areas: Infectious Diseases
Modalities: Small molecule
Industry: Biotech

Partnerships

Defense Plant Corporation (U.S. government contract during WWII)

Beyond the preview

Go deeper on Heyden Chemical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heyden Chemical.

Explore the full profile